Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chiara Chiodo"'
Autor:
Francesca De Amicis, Chiara Chiodo, Catia Morelli, Ivan Casaburi, Stefania Marsico, Rosalinda Bruno, Diego Sisci, Sebastiano Andò, Marilena Lanzino
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Androgens, through their own receptor, play a protective role on breast tumor development and progression and counterbalance estrogen-dependent growth stimuli which are intimately linked to breast carcinogenesis. Methods Cell coun
Externí odkaz:
https://doaj.org/article/1a13d4ded40841ddbcfe18471d68fc6a
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 424, p 424 (2022)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Breast cancer prevention is a major challenge worldwide. During the last few years, efforts have been made to identify molecular breast tissue factors that could be linked to an increased risk of developing the disease in healthy women. In this conce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e016f11c3bfe0be00233aefb4555d180
https://www.mdpi.com/1422-0067/23/1/424
https://www.mdpi.com/1422-0067/23/1/424
Autor:
Scott Lovell, Ludivine Morisset, Robert Clarke, Daniel Conole, Elisabetta Marangoni, Angélica Santiago-Gómez, Aida Sarmiento-Castro, D Alferez, Sacha J Howell, Katherine Spence, Bertram Kohler, Edward W. Tate, Tiago Moreira, Chiara Chiodo, Bruno M Simões, Andrew H. Sims, Sebastiano Andò, Marilena Lanzino, Rachel Eyre
Publikováno v:
M Simoes, B, Santiago-Gómez, A, Chiodo, C, Moreira, T, Conole, D, Lovell, S, Alferez-Castro, D, Eyre, R, Spence, K, Sarmiento Castro, A, Kohler, B, Morisset, L, Lanzino, M, Ando, S, Marangoni, E, Sims, A H, Tate, E, Howell, S & Clarke, R 2020, ' Targeting STAT3 signaling using stabilised sulforaphane (SFX-01) inhibits endocrine resistant stem-like cells in ER-positive breast cancer ', Oncogene, vol. 39, no. 25, pp. 4896–4908 . https://doi.org/10.1038/s41388-020-1335-z
Oncogene
Oncogene
Estrogen receptor (ER) positive breast cancer is frequently sensitive to endocrine therapy. Multiple mechanisms of endocrine therapy resistance have been identified, including cancer stem-like cell (CSC) activity. Here we investigate SFX-01, a stabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a29ad6ff20d67551f7e765115198540c
https://doi.org/10.1038/s41388-020-1335-z
https://doi.org/10.1038/s41388-020-1335-z
Autor:
Diego Sisci, Loredana Mauro, Francesca Giordano, Marilena Lanzino, Stefania Marsico, Francesca Ida Montalto, Sebastiano Andò, Saveria Aquila, Chiara Chiodo, Maria Luisa Panno, Francesca De Amicis
Publikováno v:
Cancers
Cancers, Vol 11, Iss 8, p 1201 (2019)
Volume 11
Issue 8
Cancers, Vol 11, Iss 8, p 1201 (2019)
Volume 11
Issue 8
Progesterone-Receptor (PR) positivity is related with an enhanced response to breast cancer therapy, conversely cyclin D1 (CD1) is a retained marker of poor outcome. Herein, we demonstrate that hydroxyprogesterone (OHPg) through progesterone receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ee60ed9188e23455ea8bea986a96028
https://doi.org/10.3390/cancers11081201
https://doi.org/10.3390/cancers11081201
Autor:
Chiara Chiodo, S. Andò, Loredana Mauro, S. Aquila, Francesca Ida Montalto, D. Naimo, F. De Amicis, Marilena Lanzino
Publikováno v:
ESMO Open. 3:A81
Introduction Progesterone Receptor (PR) positivity is associated with a good prognosis and better response to breast cancer treatment. Conversely, cyclin D1 (CD1) is retained a marker of poor outcome since it has been associated with breast cancer me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a28fba4f2d61dfe06b5f4f666c861c9
https://doi.org/10.1136/esmoopen-2018-eacr25.194
https://doi.org/10.1136/esmoopen-2018-eacr25.194
Autor:
Diego Sisci, Chiara Chiodo, Marilena Lanzino, Francesca Ida Montalto, S. Aquila, S. Andò, Catia Morelli, Stefania Marsico, F. De Amicis
Publikováno v:
ESMO Open. 3:A43
Introduction Androgen receptor (AR) expression in breast cancer growth and progression appears to be clinically relevant and disease context specific. In oestrogen receptor (ER)α-positive primary breast cancers, AR positivity correlates with lower t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::632aec771bbf33d2c0b9ef9ffd074e08
https://doi.org/10.1136/esmoopen-2018-eacr25.102
https://doi.org/10.1136/esmoopen-2018-eacr25.102